mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
-0.058 |
0.3 |
mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.3 |
mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
BMS-345541 |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.3 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.3 |
mRNA |
OSI-930 |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.3 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.3 |
mRNA |
AEW541 |
CCLE |
pan-cancer |
AAC |
0.048 |
0.3 |
mRNA |
Platin |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |